Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients

Launched by HACETTEPE UNIVERSITY · Aug 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how a person’s body makeup, mental and emotional well-being, and any problems with medications might affect how cancer patients respond to treatment with immune checkpoint inhibitors—a type of cancer therapy. Researchers want to understand how these factors influence treatment side effects, how well the treatment works, and overall quality of life during cancer care.

Adults aged 18 and older who have had a specific type of CT scan before starting treatment may be eligible to join. Participants need to be able to communicate clearly and not have any severe mental health issues. If you join, you can expect your body composition and psychosocial health to be evaluated alongside your treatment progress. This study aims to help doctors better personalize cancer treatment and improve support for patients dealing with side effects or other challenges during therapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18 years or older
• • Having undergone a CT scan (at the L3 level) prior to treatment
• • No severe mental disorder and able to communicate effectively
• • Provided written informed consent
• Exclusion Criteria:
• • Did not provide written informed consent
• • Patients deemed unsuitable by the physician